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Purpose: To develop citrate crosslinked chitosan films using chitosan of different molecular weights 
(MW) in order to achieve site-specific delivery of a model non-polar drug, indomethacin. 
Methods: Films prepared with different molecular weights of chitosan and incorporating indomethacin 
as a non-polar model drug were obtained by a casting/solvent evaporation method. The chitosan films 
were crosslinked by dipping in varying concentrations of sodium citrate solution and for different 
crosslinking times. The films were assessed by, amongst others, scanning electron microscopy (SEM), 
dissolution studies and differential scanning calorimetry (DSC) for surface morphology, drug release and 
ingredient compatibility, respectively.  
Results: Crosslinking time and concentration of crosslinking agent significantly (p < 0.05) influenced the 
in vitro release of indomethacin as well as swelling of the films. Also, the higher the molecular weight 
(MW) of chitosan the lower the drug release rate (p < 0.05). Furthermore, film swelling index rose as 
chitosan MW decreased (p < 0.05). The practical absence of the sharp endothermic peak characteristic 
of indomethacin in the films suggests that crosslinking may have transformed the drug from the 
crystalline to the amorphous state.  
Conclusion: The citrate-crosslinked chitosan films can be modulated to vary swelling and drug release 
at pH 3.5 and 6.2; this feature makes them useful tools for designing site-specific delivery systems. 
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INTRODUCTION 
 
A major feature of medicines development 
today is the design of suitable vehicles for 
drug delivery. Delivery vehicles for 
therapeutic compounds must be 
biocompatible and nontoxic [1]. Many of 
these systems are pH/thermo-sensitive or 
osmotically driven [2]. Thin polymer films 
have also been employed to control drug 
release for various routes of administration, 
such as transdermal, colonic, localized, and 
ophthalmic. Mucoadhesive polymeric film 
formulations can circumvent limitations 
caused by conventional vaginal formulations 
such as tablets and creams [3]. For example, 
the release of paclitaxel from PVP-g-PLGA 
film was found to be continuous and not 
preceded by initial drug burst [4].  
 
Time- or pH-dependent polymers are often 
used to target delivery of therapeutic 
substances to sites of action [5]. Several 
studies have associated drug release kinetics 
with the type of drug and device geometry. 
For instance, Klose et al studied these factors 
in PLGA-based drug delivery systems [6] 
while results from other studies indicate that 
polymer films are promising carriers for 
ophthalmic, localized and transdermal drug 
delivery systems [7]. Various 
polymethacrylate films have been evaluated 
for insulin colonic drug delivery [8].  
 
Chitosan [α (1-4) 2-amino-2-deoxy-beta-D-
Glucan] is the deacetylated derivative of 
chitin. It has recently attracted much interest 
in the biomedical industry because of its 
biodegradability, biocompatibility, 
antimicrobial activity, and accelerated wound 
healing properties [9]. Due to its unique 
polymeric cationic character as well as gel 
and film forming properties, chitosan has 
been extensively examined for various 
pharmaceutical applications. Several drug 
delivery formulations based on chitosan, such 
as film, beads, microspheres, etc, have been 
prepared using chemical cross-linking 
methods. For example, Emmanuel et al 
demonstrated the in vitro and in vivo zero-
order drug release properties and 
biocompatibility of a chitosan-based 
implantable film and its potential usefulness 
in the sustained and local delivery of anti-
neoplastic agents such as paclitaxel [10].  
 
When chitosan is dissolved in dilute acetic 
acid solutions, the amino groups become 
protonated and associated with acetate 
counter-ions, making the charged polymer 
soluble [11]. Chitosan films have been 
usually prepared by chemical crosslinking via 
electrostatic interaction between multivalent 
phosphates and chitosan in the formulation 
[12]. Chitosan crosslinked films swell under 
acidic conditions due to the ionization of 
amino groups but remains in a shrunken 
state under neutral conditions. Chitosan itself 
has intragastric-floating characteristics and 
can cause prolonged retention of the dosage 
form in the stomach [13].  
 
Controlled release of ciprofloxacin 
hydrochloride from chitosan/polyethylene 
glycol blend films produced by the casting-
solvent evaporation method has been 
evaluated [14]. It has also been shown that 
due to electrostatic interaction between 
sodium citrate and chitosan, citrate/chitosan 
film may be useful in drug delivery such as 
site–specific controlled release in stomach 
and also as epidermal sheets for humans, 
rats, and rabbits [15]. Polymer molecular 
weight has a major effect on chitosan 
properties [16], and it has also been shown 
that the thermo-sensitive characteristics, 
appearance and structure of the hydrogel as 
well as drug release from it are affected by 
chitosan MW and degree of deacetylation 
[17]. In this paper, we sought to prepare 
citrate-crosslinked chitosan films using three 
different molecular weights (MWs) of chitosan 
and investigated whether or not chitosan MW 
affects some properties of the indomethacin- 
containing films. 
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EXPERIMENTAL 
 
Materials   
 
Indomethacin (1-(p-chlorobenzoyl)-5-metho-
xy-2-methylindole-3-acetic acid), produced by 
Medichem, Spain, was used as a model 
hydrophobic drug. Low, medium and high 
molecular weight grades of chitosan (85 % 
deacetylation) were purchased from Fluka 
AG, Switzerland while sodium citrate 
(analytical grade) and other reagents were 




The interaction between sodium citrate and 
chitosan was investigated by turbidimetric 
titration [18]. Briefly, a solution of 0.2 g/L 
sodium citrate and 0.2 g/L chitosan at pH 1.0 
was prepared. The titrant (0.2M NaOH) was 
delivered with a microburette into 50 ml of the 
citrate/chitosan solution with constant stirring 
at 25 ± 0.5 °C and with the pH monitored by a 
digital pH meter (Metrohm 780, Switzerland). 
Changes in turbidity were monitored at 420 
nm with an UV-Vis spectrophotometer 
(Genesys TM2, USA  and reported as 100 % 
transmittance.  
 
Preparation of crosslinked chitosan films 
 
Chitosan solution (4 %w/v), was prepared by 
dissolving chitosan in 4 %w/v acetic acid and 
then indomethacin (1 %w/v) was dispersed in 
the solution. This was done for each MW 
grade of chitosan. The mixture (100 ml) was 
left to stand until trapped air bubbles 
disappeared and then was poured on a glass 
plate. The poured solution was allowed to dry 
in a hot air oven (Pars Azma 1597) at 37 °C 
to constant weight. The resulting dry films 
were cut into 4 cm diameter disks and 
crosslinked soaking in 100 ml aqueous 
solution of sodium citrate 4 °C.  Other 
crosslinking conditions were: 0.5 - 10 %w/v 
sodium citrate; solution pH of 5 - 7; and 
crosslinking time of 0.5 - 4.0 h. The 
crosslinked films were then rinsed in 20 ml of 
distilled water, transferred to a glass plate 
and oven-dried at 37 °C to a constant weight. 
Drug loss during the crosslinking process 
was determined spectrophotometrically at 
318 nm. 
 
Measurement of film thickness 
 
The thickness of the dried films was 
measured with a micrometer (model 2050-08, 
Mitutoyo, Japan). Five measurements were 
taken at randomly selected points on each 




The surface morphology of the crosslinked 
films was assessed by scanning electron 
microscopy (model 2360, Leo Oxford, 
England) after the films were first coated with 
gold. 
 
Evaluation of swelling ratio 
 
Blank citrate/chitosan films were suspended 
in glass bottles containing 250 ml of medium 
(either phosphate buffer, pH 6.2, or acetate 
buffer, pH 3.5) and placed in a shaker water-
bath (at 37 °C, 50 rpm). At 30 min intervals, 
the films were taken out, the excess water 
blotted out carefully with filter paper from the 
film surface and then weighed immediately. 
The swelling ratio (Wt/W0) was determined 
(where Wt was the film weight at time t and 




Indomethacin release from the films was 
evaluated by USP dissolution method V 
(paddle over disk method) in 750 ml 
phosphate buffer (pH 6.2) or acetate buffer 
(pH 3.5) at 37 °C and at a stirring rate of 50 
rpm, using Erweka dissolution tester (model 
DT 80). Samples (5 ml) were withdrawn from 
the medium at various time intervals and the 
medium replenished immediately with the 
same volume of fresh dissolution medium. 
The amount of dissolved indomethacin in the 
sample taken was measured (after filtration) 
spectrophotometrically at 318 nm. 
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Indomethacin concentration in each sample 













   …………..  (1) 
where Cn = true concentration of sample, 
Cnmass = apparent concentration of sample, 
V = volume of sample, and Vt = total volume 
of dissolution fluid. 
  
Differential scanning calorimetry (DSC) 
 
Differential scanning calorimetric studies 
were conducted in a Perkin Elmer DSC 
facility,using a sample size of approx. 5 mg in 
a loosely covered aluminum pan and heated 
in nitrogen atmosphere from 50 to 250 °C at 
a rate of 10°C/min. An empty loosely covered 




Experimental results were expressed as 
mean ± standard deviation (SD). Student’s t-
test and one-way analysis of variance 
(ANOVA) were applied to check significant 
differences in drug release, and swelling 
studies for different film formulations. 
Differences were considered to be 




Film thickness and drug content 
 
Table 1 shows the mean thickness and drug 
content of the films prepared at varying 
combinations of crosslinking concentration 
and time. The results show that there was no 
significant difference (p > 0.05) between the 
films in terms of film thickness or drug 
content.  
 
Citrate – chitosan interaction 
 
The turbidimetric titration curve of sodium 
citrate/chitosan (not shown) indicated that in 
acidic conditions (pH 1 - 4), the solution was 
clear; thereafter, it became turbid as the pH 
further rose but reverted to a clear solution 
(i.e., no interaction) at pH ≥ 7.  
Table 1: Mean thickness and drug content of 





SEM photomicrographs (not shown) indicate 
that the inner surface of the films (which 
interfaced with the glass plate) was smooth 
while the outer surface was relatively rough. 
Crosslinking hardly had any noticeable effect 
on the surface morphology of the films. 
However, all the films were yellowish cream 
in colour, with the colour deepening and film 
texture becoming more tender with increase 




The swelling data are shown in Fig 1. They 
indicate that at pH 6.2, film swelling for all 
three chitosan MW grades was significantly 
(p < 0.05) affected by crosslinking time. All 
the MW grades showed higher swelling in 
acid conditions (pH 3.5) than at pH 6.2. 
Furthermore, at pH of 3.5, swelling 
decreased as MW of chitosan rose.  











    
F1 - - 36.3±1.2 100.0 
F2 0.5 0.5 40.0±0.8 100.0 
F3 0.5 10 36.7±0.5 98.5 
F4 4.0 0.5 39.3±1.7 98.5 
















F7 0.5 0.5 33.3±1.2 100.0 
F8 0.5 10 43.3±1.2 99.1 
F9 4.0 0.5 41.7±1.7 99.0 
















F12 0.5 0.5 35.0±1.6 99.3 
F13 0.5 10 39.7±0.9 98.4 
F14 4.0 0.5 37.0±1.4 98.1 
F15 4.0 10 38.3±0.9 98.6 
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Drug release studies:  
 
Fig 2 shows that indomethacin was released 
rapidly from the film matrix at pH 3.5. Drug 
release was independent of either 
crosslinking time or concentration (p > 0.05). 
The results also show that drug release rate 
decreased significantly at pH 3.5 (p < 0.05) 
as chitosan MW increased. On the other 
hand, at pH 6.2, as Fig 3 indicates, drug 
release was significantly decreased by cross 
linking time and/or concentration of 
crosslinking agent (p < 0.05). The greater the 





Fig 1:  Swelling ratio of chitosan films (○ =  LMW, 




Fig 2: Release of indomethacin from chitosan 
films in pH 3.5 medium:  ■ = F1; □ = F3;  ■ = F5;  
▲ =  F6,   ∆ F8,    ▲ F10, ●    F11,  ○   F13,   ●   





Fig 3: Release of indomethacin from chitosan 
films in pH 6.2 medium (■ = F1; □ = F3; ■ = F5; 
▲= F6; ∆ = F8; ▲= F10; ● = F11; ○ = F13; ● = 
F15 (Code key as in Table 1)  
 
There was no significant difference between 
low and medium MW grades of chitosan in 
terms of the drug release rate of the films (p > 
0.05). However, high MW chitosan film 
showed a slight decrease in the rate of drug 




The DSC thermograms of pure indomethacin 
and some of the chitosan films are shown in 
Fig 4. The thermogram of.indomethacin (A) 
showed a sharp endothermic peak at 165 °C 
which indicates the melting transition of the 
drug. The thermogram of F6 (B), which was 
similar to those of F1, F5, F10, F11 and F15 
(not shown), manifested a broad endothermic 
peak. A combination of the highest 
crosslinking concentration (10 % sodium 
citrate) and longest cross-linking time (4 h) 
for the different MW grades of chitosan 
caused a depression of the endothermic peak 
in the film thermograms by approximately 57, 




Citrate is an anion with three carboxylic 
groups and chitosan is polybasic with cations. 
The charge densities of citrate and chitosan 
are mainly controlled by solution pH 13-14]. 
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Under neutral and weakly acidic conditions, 
the degree of ionization of sodium citrate 
significantly decreased owing to the weak 
acid characteristics of citric acid. In contrast, 
chitosan, being a weak polybase, showed a 
marked decrease in the ionization of its 
amine groups when solution pH increased to 
over 6.0 (chitosan pKa = 6.3)[19]. 
 
 
Fig 4: DSC thermograms of pure indomethacin (A) 
and chitosan films (B = F6, C = F11, and D = F1)  




The pH of the medium had a major effect on 
chitosan film swelling due to the ionization of 
both the sodium citrate and chitosan. 
Swelling ratio was lowest at pH of 5.5 and 
6.5, owing to electrostatic attraction between 
citrate and chitosan. Reduction in pH 
weakened the salt bonds and, therefore, 
facilitated chitosan film swelling. However, 
increase in pH above 6.5 would probably also 
have weakened the salt-bonds and produced 




Drug release from the films was sensitive to 
pH because electrostatic interaction between 
the citrate anion and chitosan amine groups 
were influenced by solution pH. Decrease in 
pH weakened the salt bonds and therefore, 
facilitated film swelling, thereby making it 
more porous and accelerating drug release. 
pH also has been reported to have a slight 
effect on the solubility of indomethacin [20]. A 
lower pH leads to improved solubility of drug 
and this in turn results in higher drug release 
rate. However, compared to the strong 
influence of pH on the film matrix, pH effects 
on drug solubility was negligible. At low pH 
(1.0 - 3.5), sodium citrate and chitosan would 
be in a dissociated state and hence drug 
release from the films was rapid. As the 
results show the greater the crosslinking 
time, the lower was the drug release rate, 
This may be attributed to a higher degree of 
crosslinking in the matrix, leading to delay in 
the diffusional release of the drug. A slight 
decrease in the rate of drug release in acid 
conditions for high MW chitosan film maybe 
related to its higher viscosity compared with 
low and medium MWs.  
 
Although the protonation constant (pKa) of 
chitosan slightly decreases (from 6.51 to 
6.39) with decrease in its MW [19], in acid 
conditions (pH 3.5), a slight decrease in pKa 
appeared not to have played a major role in 
drug release rate due to high dissociation at 




The absence of a sharp endothermic melting 
peak for indomethacin in the thermograms of 
these films may be due to the conversion of 
the incorporated indomethacin from the 





The variations in citrate-crosslinked chitosan 
film swelling and as well as in drug release 
rate in medium pH of 3.5 and 6.2 suggest 
that this type of films can be modulated to 
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